APGCS 2026: Bridge Between Breakthrough Research and Bedside Application
APGCS

APGCS 2026: Bridge Between Breakthrough Research and Bedside Application

Asia-Pacific Gastroenterology Cancer Summit (APGCS) shared a post on LinkedIn:

Why the Region’s Leading Oncologists Return to APGCS.

In a field where clinical data evolves overnight, APGCS 2026 remains the definitive arena for medical professionals to bridge the gap between breakthrough research and bedside application. As Dr. Jennifer Leong notes, it isn’t just about the sessions—it’s about the high-level collaborative network that drives oncology forward in the Asia-Pacific. Don’t let the clinical curve outpace your practice.

Share this video with a colleague who needs to be in Singapore this August—let’s ensure the best minds in GI oncology are in the room.

Deadline: April 30, 2026 Register at: apgcs.com

Other articles featuring APGCS on OncoDaily.